Search Results

Safety and efficacy of biologic immunosuppressive treatment in juvenile idiopathic arthritis associated with inborn errors of immunity.

• Authors : Accardo, V.; Pagnini, I.; Maccora, I.

• Source: Frontiers in Pediatrics; 2024, p1-5, 5p

Record details

Too young to fail: a case report on the effectiveness of tocilizumab for paediatric systemic sclerosis-associated interstitial lung disease.

• Authors : Maniscalco, V¹ (AUTHOR) ; Marrani, E¹ (AUTHOR); Rossi, E² (AUTHOR)

Subjects: *INTERSTITIAL lung diseases; *PEDIATRICS; *TOCILIZUMAB

• Source: Scandinavian Journal of Rheumatology. Nov 2021, Vol. 50 Issue 6, p491-492. 2p.

Record details

CLINICAL MANIFESTATIONS AT THE ONSET OF PEDIATRIC MIXED CONNECTIVE TISSUE DISEASE (PMCTD): A SYSTEMATIC REVIEW.

• Authors : Terminiello, A.; Marrani, E.; Pagnini, I.

• Source: Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p1939-1940, 2p

Record details

APPLICATION OF CRISS SCORE, REVISED CRISS SCORE AND RCID SCORE IN PATIENTS WITH JUVENILE SYSTEMIC SCLEROSIS.

• Authors : Klotsche, J.; Foeldvari, I.; Torok, K.

• Source: Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p290-291, 2p

Record details

The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study

• Authors : Marrani, E.; Cimaz, R.; Lucherini, O M

• Source: Pediatric Rheumatology. October 6, 2015, Vol. 13 Issue 1

Record details

UVEITIS AS PREDICTORS OF RELAPSE AFTER ANTI-TNF TREATMENT WITHDRAWAL IN JUVENILE IDIOPATHIC ARTHRITIS: AN ITALIAN MULTICENTRIC EXPERIENCE.

• Authors : Maccora, I.; Trevisan, M.; Accardo, V.

• Source: Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p670-670, 1/2p

Record details

PATIENT AND PHYSICIAN REPORTED OUTCOMES OF JUVENILE SYSTEMIC SCLEROSIS PATIENTS SIGNIFICANTLY IMPROVE OVER 24 MONTHS OBSERVATION PERIOD IN THE JUVENILE SYSTEMIC SCLERODERMA INCEPTION COHORT.

• Authors : Foeldvari, I.; Klotsche, J.; Kasapcopur, O.

• Source: Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p290-290, 1/2p

Record details

Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022.

• Authors : Foeldvari I; Hamburg Centre for Pediatric and Adolescent Rheumatology, Schön Klinik Hamburg Eilbek, Hamburg, Germany.; Torok KS

Subjects: Scleroderma, Localized* ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/drug therapy; Child Juvenile systemic scleroderma; Juvenile-onset scleroderma

• Source: Expert review of clinical immunology [Expert Rev Clin Immunol] 2024 Apr; Vol. 20 (4), pp. 387-404. Date of Electronic Publication: 2024 Jan 02.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101271248 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Comment on: Achieving inactive disease in enthesitis-related arthritis with secukinumab following TNF-inhibitor failure.

• Authors : Maniscalco V; Rheumatology Unit, ERN-ReCONNET center, Meyer Children's Hospital IRCCS, Florence, Italy.; Pagnini I

• Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Mar 09. Date of Electronic Publication: 2024 Mar 09.Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Childhood mixed connective tissue disease at disease onset: Evidence from a systematic review.

• Authors : Terminiello A; Department of Health Sciences, University of Florence, Florence, Italy. Electronic address: .; Marrani E

• Source: Autoimmunity reviews [Autoimmun Rev] 2024 Jan 06; Vol. 23 (4), pp. 103513. Date of Electronic Publication: 2024 Jan 06.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128967 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details